SCHEMBL3343763

SCHEMBL3343763

Cc1nc(C(=O)N2CCOC2C(N)=O)c(-c2ccc(C)c(C)c2)s1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 20/20 0.49
HCRTR2 O43614 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3350764 0.88 HCRTR1 (0.50) HCRTR1HCRTR2
SCHEMBL3348068 0.87 HCRTR1 (0.54) HCRTR1HCRTR2
SCHEMBL3343784 0.87 HCRTR1 (0.51) HCRTR1HCRTR2
SCHEMBL3343770 0.85 HCRTR1 (0.49) HCRTR1HCRTR2
SCHEMBL1398992 0.82 HCRTR1 (0.54) HCRTR1HCRTR2
SCHEMBL1028664 0.80 HCRTR1 (0.49) HCRTR1HCRTR2
SCHEMBL3345948 0.79 HCRTR2 (0.38) HCRTR1HCRTR2
SCHEMBL3315038 0.78 HCRTR1 (0.50) HCRTR1HCRTR2
SCHEMBL1398994 0.77 HCRTR1 (0.54) HCRTR1HCRTR2
SCHEMBL3411993 0.77 HCRTR1 (0.49) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010038200-A1 OXAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-04-08 WO claimed
WO-2010038200-A1 OXAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2010-04-08 WO disclosed